Share This Author
Identification of a novel variant of hepatitis E virus in Austria: sequence, phylogenetic and serological analysis.
- H. C. Worm, G. Schlauder, H. Wurzer, I. Mushahwar
- BiologyThe Journal of general virology
- 1 December 2000
The results show that HEV-Au1 is significantly divergent from other HEV isolates, verifying the presence of an additional HEV variant in an industrialized country and providing information about possible problems in detecting anti-HEV.
Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro‐oesophageal reflux disease
- K. Plein, J. Hotz, H. Wurzer, I. Fumagalli, R. Lühmann, A. Schneider
- MedicineEuropean journal of gastroenterology & hepatology
- 1 April 2000
Both the 20 mg and 40 mg doses of pantoprazole are safe and effective in maintaining patients with healed reflux oesophagitis in remission, and for the majority of patients, the 20mg dose provides adequate long‐term therapeutic efficacy at a minimal drug exposure and lower costs.
Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
In patients with recurrent duodenal ulcer, eradication of H. pylori by a regimen that does not have any direct action on the mucosa is followed by a marked reduction in the rate of recurrence, suggesting a causal role for H.
Influence of spasmolytic analgesics on motility of sphincter of oddi
Dipyrone, in contrast to tramadol and indomethacin, exhibits spasmolytic activity in addition to analgesia in biliary pain, and is effective in patients hospitalized with upper abdominal pain.
Short‐course therapy with amoxycillin–clarithromycin triple therapy for 10 days (ACT‐10) eradicates Helicobacter pylori and heals duodenal ulcer
Whilst the role of Helicobacter pylori eradication in managing duodenal ulcers has been established, consensus regarding the ideal regimen has not been achieved.
Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.
- H. Wurzer, K. Schutze, T. Bethke, R. Fischer, R. Luhmann, C. Riesenhuber
- 1 May 1999
Pantoprazole (40 mg), applied as an intravenous-oral regimen to patients with GERD led to fast resolution of symptoms and high healing rates, and allows the possibility of changing between the oral and intravenous administration without the need for dose adjustment.
Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori.
Ranitidine Bismuth Citrate With Clarithromycin Given Twice Daily Effectively Eradicates Helicobacter pylori and Heals Duodenal Ulcers
Contrast-enhanced ultrasound detects gallbladder perforation in a patient with acute abdominal pain.
Lewis and ABO histo‐blood types and the secretor status of patients hospitalized with COVID‐19 implicate a role for ABO antibodies in susceptibility to infection with SARS‐CoV‐2
The antigens investigated may not be prognostic for disease severity, but a role for ABO isoagglutinins in SARS-CoV-2 infections is strongly suggested.